MEI Pharma is a clinical-stage pharmaceutical company based in San Diego, California, that develops therapies for cancer. Its work centres on small-molecule drug candidates intended to treat blood cancers and solid tumours, including compounds studied in acute myeloid leukaemia and other haematologic conditions. The company's programmes are in clinical testing rather than on the market, and it works with academic and clinical collaborators to run its trials. Its customers, in effect, are the physicians and patients who would use any approved therapy.
On this site MEI Pharma Inc. appears as a stock on the London Exchange (UK), code 0JW9, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3029 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
50/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average5.8%
From 52-week high-46.0%
MomentumWeak
46/100
Lagging most stocks on this exchange.
See the numbers →
3-month return14.7%
6-month return-1.7%
12-month, skipping last month-36.3%
Stability (higher is calmer)Weak
11/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)74.9%
Worst drawdown, 1 year (smaller is calmer)-67.7%
LiquidityWeak
11/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends1
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 0.697 – 2.250Daily closes, split-adjusted
Signals
50-day average1.157
200-day average1.106
Golden/death cross (60d)Golden, 8 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.084
Technical summary
Daily
Neutral
6 bullish · 2 neutral · 8 bearish
Weekly
Bearish
4 bullish · 1 neutral · 7 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
1.20
Bearish
EMA 10
1.21
Bearish
SMA 20
1.27
Bearish
EMA 20
1.23
Bearish
SMA 50
1.16
Bullish
EMA 50
1.17
Bearish
SMA 100
1.04
Bullish
EMA 100
1.14
Bullish
SMA 200
1.11
Bullish
EMA 200
1.37
Bearish
Oscillators (daily)
RSI (14)
45.91
Neutral
MACD (12, 26)
0.00
Bearish
Momentum (12)
-10.00
Bearish
Stochastic %K (14)
12.90
Bullish
Williams %R (14)
-87.10
Bullish
CCI (20)
-71.49
Neutral
Pivot points (classic, last session)
S3
1.08
S2
1.12
S1
1.15
Pivot
1.19
R1
1.22
R2
1.26
R3
1.29
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 USD
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
1.7500
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in USD. Educational only, not financial advice.
